Back to search

University of Patras

Μελέτη συζευγμάτων σακχαριτών με πεπτίδια

Abstract

dc:description

Multiple Sclerosis (MS) is a chronic, inflammatory, immunologically controlled disease of the Central Nervous System (CNS) characterized by destruction of myelin. Myelin is a highly specialized, compact multi-layered membrane that wraps around the axons of neurons forming the myelin sheath and helping the rapid transmission of nerve impulses. Studies have shown that Myelin Oligodendrocyte Glycoprotein (MOG), although a minor component of myelin, is an important autoantigen in the development of MS and Experimental Autoimmune Encephalomyelitis (EAE), the experimental animal model for demyelinating diseases. In particular, the epitope 35-55 of the MOG protein is the dominant antigen that causes the appearance of EAE in experimental animals and is the target of immune responses in MS, inducing the production of highly specific antibodies. Developing peptide conjugates with sugars to target cells of the immune system is a common technique. Mannan (polymannose, from the yeast Saccharomyces Cerevisiae) is widely used for the transfer of proteins and peptides to the surface of antigen-presenting cells, since it targets the mannose receptor of these cells. Studies have shown that the 35-55 epitope of the MOG protein conjugated to the polysaccharide mannan in its oxidized form, via a [Lys-Gly]5 bridge, can modify the immune response of EAE and protect mice from its development. For this reason, the study of the conjugate and the chemical characteristics of the coupling reaction as well as the finding of a suitable method for the identification of the MOG35-55 peptide conjugated with the polysaccharide mannan, the investigation of the possible modifications of the peptide during the synthesis of the conjugate as well as the study of the stability of the synthesized conjugates, are important objectives, which were developed in the present doctoral thesis. The study of these conjugates was held in two ways. The first approach concerns the study of this conjugate and its components with Nuclear Magnetic Resonance (NMR) in one (1H, 13C) and two dimensions (2D COSY, 2D ROESY, 2D TOCSY, 2D HSQC and 2D HMBC). For this purpose, samples of mannose, mannan, oxidized mannan and conjugate of oxidized mannan with the peptide analogue [KG]5MOG35-55 were studied. Through the NMR study, i) analysis of the structure of the mentioned samples, ii) control of the formation of aldehyde groups during the oxidative cleavage reaction of the polysaccharide, iii) calculation of the oxidation rate and iv) control of the formation of Schiff bases in the conjugate, were studied. The second approach concerns the development of a methodology to study the stability of the synthesized conjugates and to monitor possible modifications they may undergo. For this purpose, a competitive ELISA methodology based on the [KG]5MOG35-55 epitope was developed and polyclonal antibodies against MOG36-55 were produced (by Davids Biotechnologies) by immunization of rabbits. The method was checked for its accuracy and reproducibility, but also for the possibility of false reactivity with molecules other than the antigen, followed by the study of the stability of the conjugate during storage. In addition, through the ELISA methodology, possible modifications of the conjugate were monitored. These modifications concern conversions that may occur in the epitope a) either during conjugation with mannan at basic pH 9,0, such as the deamidation of Asn to Asp and iso-Asp, b) or during peptide synthesis with Fmoc/tBu methodology, where under the acidic conditions during treatment with TFA, methionine can be oxidized to the corresponding sulfoxide, c) either in vivo, as for example the conversion of Arg residues to Cit by the action of PAD enzymes or the proteolytic cleavage of the protein by the enzyme trypsin. For this purpose, the following peptides were synthesized in solid phase, step by step, with the Fmoc/tBu methodology on 2-chlorotrityl chloride resin (ClTR-Cl): i) [KG]5MOG35-55 (Asp53); ii) [KG]5MOG35-55 (isoAsp53); iii) [KG]5MOG35-55 (Met(O)35); iv) [KG]5MOG35-55 (Cit41, 46, 52) and v) [KG]5MOG35-46. These peptides were then purified using semi-preparative RP-HPLC and identified via ESI-MS spectrometry, coupled to oxidized mannan and studied via ELISA methodology.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gkika, Areti
  • Γκίκα, Αρετή

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55744

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gkika, Areti; Γκίκα, Αρετή. Μελέτη συζευγμάτων σακχαριτών με πεπτίδια. University of Patras, 2023. http://hdl.handle.net/10442/hedi/55744